18+ Years of Experince
Know Your Doctor
Dr. Tejinder Singh
- Practicing in the field of Medical Oncology since last 18ys
- Given more than 50000+ chemotherapy/targeted therapies/immunotherapy and treated more than 100000+ patients since last 18+ yrs
- Speaker in many lectures, seminars, moderation in both international and national conferences
- Organizing since last 5 years Annual Gastrointestinal Symposium (which is a national level oncology conference)
- Part of many clinical trials’ and having multiple publications in both national and international journals
- Been in the advisory board of many multinational and national pharmaceutical companies
- Trained in Medical Oncology from Kidwai Memorial Institute of Oncology, Bangalore and also from Tata Memorial Hospital, Mumbai (Both premier teaching Institutes in the field of Oncology)
- Have special interest in treatment of breast, thoracic, brain, liver, Gastrointestinal, lymphomas, bone and soft tissue cancers
- Had privilege of starting Department of Medical Oncology in Apollo Hospital, Navi Mumbai, Fortis Hiranandani hospital, Vashi & Fortis hospital Kalyan
- Privileged to be the first qualified medical oncologist based in Navi Mumbai and also qualified DNB Medical Oncology teacher and examiner and first one from Navi Mumbai
- In Apollo hospital, Navi Mumbai, I impart medical oncology training to DNB students
- I am FOUNDER and Director of Oncoheal Clinic, Vashi, Navi Mumbai (A premier comprehensive oncology center)
Work Experience
- Practicing in the field of Medical Oncology since last 18yrs
- Given more than 50000+ chemotherapy/targeted therapies/immunotherapy
- and treated more than 100000+ patients since last 18+ yrs
- Have given many lectures, seminars, moderation in both international and national conferences and also organizing since last 5 years Annual Gastrointestinal Symposium (which is a national level oncology conference)
- Being part of many clinical trials’ and having multiple publications in both national and international journals
- Being in the advisory board of many multinational and national pharmaceutical companies
- Undergone training in medical oncology from Kidwai Memorial institute of Oncology,Bangalore and also from Tata Memorial Hospital, Mumbai
- Have special interest in treatment of breast, thoracic, brain, liver, Gastrointestinal, lymphomas,leukemias,bone and soft tissue cancers
- Had privilege of starting Department of Medical Oncology in Apollo Hospital, Navi Mumbai, Fortis Hiranandani hospital, Vashi and Fortis hospital Kalyan
- Privileged to be the first qualified medical oncologist based in Navi Mumbai.
- And also qualified DNB Medical Oncology teacher and examiner and first one from Navi Mumbai
- In Apollo hospital, Navi Mumbai, I impart medical oncology training to DNB students.
- I am FOUNDER and Director of Oncoheal Clinic, Vashi, Navi Mumbai
- Jan 2017 till date: Sr Consultant Medical Oncologist, Apollo Hospital, Navi Mumbai
- April 2012 till date: Assistant Professor and Head, Dept of Medical Oncology, Padmashree Dr. D.Y. Patil Medical College, Nerul, Navi Mumbai
- Oct 2011 till July 2019: Consultant Medical Oncology, Fortis Hiranandini Hospital, Vashi, Mumbai
- Feb 2010 till date: Reviewer of journal INDIAN PAEDIATRICS
- Dec 2010 till July 2019: Consultant Medical Oncology, Fortis Hospital, Mulund, Mumbai
- Dec 2010 till July 2019: Consultant Medical Oncology, Fortis Hospital, Kalyan, Maharashtra
- August 2010 till Dec 2010: Consultant Medical Oncology, Apollo Hospital, Bangalore
- Oct 2010 till Dec 2010: Visiting Consultant Medical Oncology, Apollo Hospital, Mysore
- Sep 2007 to July 2010: Senior Resident, Department of Medical Oncology,
- Kidwai Memorial Institute of Oncology, Bangalore, India.
- 1st Aug 2007 to 31st 2007: Senior Resident, Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
- Feb 2007 to July 2007: Lecturer, Department of Medicine, Dr. D.Y. Patil Medical College, Navi Mumbai, India.
- Aug 2006 to Jan 2007: Clinical Assistant, Medical Oncology, P.D. Hinduja Hospital, Mumbai, India
- Dec 2000 to Jan 2006: Resident, Department of Medicine, B.Y.L Nair hospital and T.N. Medical College, Mumbai, India.
- Feb 2002 to Nov 2002: Resident, Department of ENT, B.Y.L Nair hospital and T.N. Medical College, Mumbai, India.
- Aug 2001 to Jan 2002: Resident Medical Officer, Guru Nanak Hospital, Bandra, Mumbai.
Publications: Book Chapter
- Etiology and Pathogenesis of Multiple Myeloma. Education book of CME on plasma cell dyscrasias 2009, KMIO, Bangalore, India
Publications-First author
- Blindness as an initial presentation of rectal cancer with brain metastases. Letter to the editor. The Saudi Journal of Gastroenterology.Vol.15.Number 1. Jan 2009.Page 63-64.
- IgA Plasma cell Leukemia. Journal of Laboratory Physicians. Jan-Jun 2009.Vol 1.Issue 1.Page 19-21.
- Use of Port-A-Cath in pediatric cancer patients: Experience from a tertiary cancer center in south India. J Clin Oncol 27, 2009 (suppl; abstr e20747).
- Age and gender as influencing factor on treatment outcome in extensive stage small cell lung cancer (SCLC).Abstract P-40 (411-Abs-360).Indian Journal of Cancer.Vol.45.Supp.Oct 2009.
- Use of long term venous access in cancer patients: Experience from a tertiary cancer centre in South India. J Clin Oncol 26: 2008 (May 20 suppl; abstr 20710)
- Drug induced Hepatitis: The commonest culprit in clinical practice. The Journal of General April-June 2005.Vol.17 No.2.Page 29-33.
- Significance of t (8: 14) in CLL? Letter to Indian Journal of Human Genetics.
Publications-others
- Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid. Turk J Hematol 2009; 26: 97-9
- A clinical study of bone metastases in carcinoma lung. Abstract P-38 (413-Abs-454). Indian Journal of Cancer.Vol.45.Supp.Oct 2009.
- To analyze efficacy, safety and toxicity profile of Docetaxel- carboplatin gemcitabine-carboplatin in advanced NSCLC. Abstract P-5 (410-Abs-379). Indian Journal of Cancer.Vol.45.Supp.Oct 2009.
- Combination therapy with docetaxel and carboplatin in advanced NSCLC in elderly (>65 yr) - Experience from a tertiary care center from South India. Abstract P-1 (412-Abs-362). Indian Journal of Cancer.Vol.45.Supp.Oct 2009.
- HIV related malignancies: a single centre Abstract P-3505. European Journal of Cancer. Supplements, Vol 7 No 2, September 2009, Page 203.
- A comparative study of single-dose pegfilgrastim versus daily filgrastim in patients with acute myeloid leukemia. Abstract No: e18005: J Clin Oncol 27, 2009 (suppl; abstr e18005)
- To analyze efficacy and safety of pegfilgrastim versus filgrastim in patients with breast cancer .J Clin Oncol 27, 2009 (suppl; abstr e20587)
- Retrospective analysis of clinico-pathological profile of triple negative breast cancer – Experience from a tertiary care center from South India. The Breast 2009.Vol 18(Suppl 1).S71.0210
- The efficacy, toxicity profile and tolerability of cisplatin plus 5-FU versus docetaxel plus carboplatin as induction therapy in locally advanced oral cancer: an experience from a tertiary cancer centre from South India. J Clin Oncol 26: 2008 (May 20 suppl; abstr 17017)
- Dose escalation of imatinib in CML patients with sub-optimal response to conventional dosage: Is it worth it? J Clin Oncol 26: 2008 (May 20 suppl; abstr 18026)
- Nail changes induced by weekly Paclitaxel as a surrogate marker for response assessment in patients with metastatic breast cancer. J Clin Oncol 26: 2008 (May 20 suppl; abstr 12019)
- To analyze the efficacy, tolerability, toxicity profile, and pharmaco- economics of Paclitaxel-Carboplatin vs. Cisplatin-Etoposide in patients with advanced NSCLC. Journal of Thoracic Oncology • Vol. 3, No. 4, Supplement 1, 2008.
- Retrospective analysis of incidences of visceral and non visceral metastasis in triple negative and non triple negative breast cancer patients – Experience from a tertiary care center from South India. Asia–Pac J Clin Oncol 2008; 4(Suppl. 2): A114.
.png)
